Full course description


Julie Torbit

COPE Number and Category



1)  Review the 2011 revised recommendations on screening for antimalarial drug toxicity

2) Review which tests are recommended (and not recommended) for routine screening

3) Assess risk for toxicity in regards to cumulative dose, daily dose and physique

4) Understand how to manage and follow patients who are at high risk of developing toxicity